Social networks
633 8,049Activities
Technologies
Entity types
Location
7 Bd Bourdon, 75004 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 76
SIREN
828335174Engaged corporates
48Added in Motherbase
4 years, 9 months agoEmpowering Artificial Intelligence towards Precision Medicine
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare.
A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge.
Today, ART-PlanTM, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year.
TheraPanacea also develops and operates the ART-OmicsTM platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.
healthcare, radiation therapy, radiation oncology, cancer care, and artificial intelligence
Empowering Artificial Intelligence towards Precision Medicine
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare.
A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge.
Today, ART-PlanTM, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year.
TheraPanacea also develops and operates the ART-OmicsTM platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.
Reinventing cancer care through AI - Innovating technology to standardize cancer treatment planning - Adaptive radiotherapy solution
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
ZEISS Group Optical systems, Appliances, Electrical, and Electronics Manufacturing | ZEISS Group Optical systems, Appliances, Electrical, and Electronics Manufacturing | Not capitalistic Partnership Not event 4 Mar 2019 | | |
Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Capitalistic Partnership Not event 31 Jan 2022 6 Jun 2024 | | |
Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Not capitalistic Partnership Event 11 Oct 2019 5 Jul 2023 | | |
Elsevier Publishing, IT Services and IT Consulting | Elsevier Publishing, IT Services and IT Consulting | Other 27 Sep 2024 | | |
Start in Saclay Startup accelerator & VC, Civic and Social Organizations | Start in Saclay Startup accelerator & VC, Civic and Social Organizations | Other 8 Dec 2017 | | |
SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | SATT Paris-Saclay Research, Startup accelerator & VC, Research Services | Not capitalistic Partnership Event 26 Jan 2021 4 Apr 2024 | | |
Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Health, Medical Practices | Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Health, Medical Practices | Other 5 Nov 2024 | | |
Technofounders Research, Research Services | Technofounders Research, Research Services | Not capitalistic Not partnership Event 15 Dec 2017 | |